Lilly’s Humalog Authorized Generic Will Not Quash Price Pressure

 
• By Dave Wallace

Eli Lilly has announced plans to introduce a generic version of its Humalog insulin lispro in the US at a 50% discount to the brand’s list price. However, political pressure is continuing to mount over the lack of availability of cheaper alternatives.

ClampCoins
Political Pressure On Insulin Pricing Continues Despite Lilly’s Launch • Source: Shutterstock

More from Products

More from Generics Bulletin